Format

Send to

Choose Destination
Nat Genet. 2018 Dec;50(12):1620-1623. doi: 10.1038/s41588-018-0217-6.

Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution.

McDonald TO1,2,3,4, Chakrabarti S1,2,4, Michor F5,6,7,8.

Author information

1
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
2
Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
3
Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA.
4
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
5
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. michor@jimmy.harvard.edu.
6
Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA. michor@jimmy.harvard.edu.
7
Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA. michor@jimmy.harvard.edu.
8
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. michor@jimmy.harvard.edu.
PMID:
30374067
PMCID:
PMC6467055
DOI:
10.1038/s41588-018-0217-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center